Back
Blueprint Medicines Quote, Financials, Valuation and Earnings
Sponsored
BPMC
Sponsored
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Buy
55
BPMC
Blueprint Medicines
Last Price:
91.68
Seasonality Move:
11.38%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!Blueprint Medicines Price Quote
$91.68
-1.42 (-1.53%)
(Updated: April 30, 2024 at 3:45 PM ET)
Blueprint Medicines Key Stats
Buy
55
Blueprint Medicines (BPMC)
is a Buy
Day range:
$91.12 - $94.91
52-week range:
$43.89 - $101.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
22.61
P/B ratio:
43.65%
Volume:
622.9K
Avg. volume:
696.1K
1-year change:
82.37%
Market cap:
$5.7B
Revenue:
$249.4M
EPS:
$-8.36
How Much Does Blueprint Medicines Make?
-
How Much Are Blueprint Medicines's Sales Annually?
BPMC Revenues are $249.4M -
How Much Profit Does Blueprint Medicines's Make A Year?
BPMC net income is -$507M
Is Blueprint Medicines Growing As A Company?
-
What Is Blueprint Medicines's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.86% -
What Is Blueprint Medicines's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Blueprint Medicines Stock Price Performance
-
Did Blueprint Medicines Stock Go Up Last Month?
Blueprint Medicines share price went down by -1.86% last month -
Did BPMC's Share Price Rise Over The Last Year?
BPMC share price rose by 82.37% over the past 1 year
What Is Blueprint Medicines 52-Week High & Low?
-
What Is Blueprint Medicines’s 52-Week High Share Price?
Blueprint Medicines has traded as high as $101.00 over the past 52 weeks -
What Is Blueprint Medicines’s 52-Week Low Share Price?
Blueprint Medicines has traded as low as $43.89 over the past 52 weeks
Blueprint Medicines Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Blueprint Medicines?
-
How Much Debt Does Blueprint Medicines Have?
Total long term debt quarterly is $238.8M -
How Much Cash Does Blueprint Medicines Have?
Cash and short term investments quarterly total is $710.6M -
What Is Blueprint Medicines’s Book Value Per Share?
Book value per share is 2.14
Is Blueprint Medicines Cash Flow Positive?
-
What Is BPMC Cash Flow From Operations?
Cash flow from operations (TTM) is -$436.8M -
What Is Blueprint Medicines’s Cash Flow From Financing?
Cash flow from financing (TTM) is $119.2M -
What Is Blueprint Medicines’s Cash Flow From Investing?
Cash flow from investing (TTM) is $274M
Blueprint Medicines Return On Invested Capital
-
Is Management Doing A Good Job?
BPMC return on invested capital is -102.67% -
What Is Blueprint Medicines Return On Assets?
ROA measures how assets are converting to revenues and is -43.47% -
What Is BPMC Return On Equity?
ROE is a measure of profitability and is -161.12%
Blueprint Medicines Earnings Date & Stock Price
-
What Is Blueprint Medicines's Stock Price Today?
A single share of BPMC can be purchased today for 93.10 -
What Is Blueprint Medicines’s Stock Symbol?
Blueprint Medicines trades on the nasdaq under the ticker symbol: BPMC -
When Is Blueprint Medicines’s Next Earnings Date?
The next quarterly earnings date for Blueprint Medicines is scheduled on May 2, 2024 -
When Is BPMC's next ex-dividend date?
Blueprint Medicines's next ex-dividend date is April 30, 2024 -
How To Buy Blueprint Medicines Stock?
You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Blueprint Medicines Competitors
-
Who Are Blueprint Medicines's Competitors?
Below is a list of companies who compete with Blueprint Medicines or are related in some way:
Blueprint Medicines Dividend Yield
Data Unavailable
Blueprint Medicines Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 11.48% |
Revenue: | 85.55% | 7.23% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 1 |
Price Target: | 98.06 |
Upside from Last Price: | 5.33% |